Clinical pharmacokinetics and pharmacodynamics of artemisinin and derivatives.
Reliable and reproducible methods for the measurements of artemisinin and its derivatives in body fluids have proved difficult to develop. The available evidence suggests that all compounds are hydrolysed to a biologically active metabolite, dihydroartemisinin, which is eliminated rapidly. The role...
Κύριος συγγραφέας: | White, N |
---|---|
Μορφή: | Conference item |
Έκδοση: |
1994
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Population pharmacokinetic and pharmacodynamic modeling of artemisinin resistance in Southeast Asia
ανά: Lohy Das, J, κ.ά.
Έκδοση: (2017) -
Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine
ανά: André Daher, κ.ά.
Έκδοση: (2019-09-01) -
Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine.
ανά: White, N, κ.ά.
Έκδοση: (1999) -
Clinical pharmacokinetics and pharmacodynamics of artemether-lumefantrine
ανά: White, N, κ.ά.
Έκδοση: (1999) -
Population pharmacokinetic and pharmacodynamic properties of artesunate in patients with artemisinin sensitive and resistant infections in Southern Myanmar
ανά: Das, J, κ.ά.
Έκδοση: (2018)